Circulating anti-Müllerian hormone and breast cancer risk: A study in ten prospective cohorts
<p>A strong positive association has been observed between circulating anti-Müllerian hormone (AMH), a biomarker of ovarian reserve, and breast cancer risk in three prospective studies. Confirming this association is important because of the paucity of biomarkers of breast cancer risk in preme...
Автори: | Ge, W, Clendenen, TV, Afanasyeva, Y, Koenig, KL, Agnoli, C, Brinton, LA, Dorgan, JF, Eliassen, AH, Falk, RT, Hallmans, G, Hankinson, SE, Hoffman-Bolton, J, Key, TJ, Krogh, V, Nichols, HB, Sandler, DP, Schoemaker, MJ, Sluss, PM, Sund, M, Swerdlow, AJ, Visvanathan, K, Liu, M, Zeleniuch-Jacquotte, A |
---|---|
Формат: | Journal article |
Опубліковано: |
Wiley
2018
|
Схожі ресурси
Схожі ресурси
-
Breast cancer risk prediction in women aged 35–50 years: impact of including sex hormone concentrations in the Gail model
за авторством: Tess V. Clendenen, та інші
Опубліковано: (2019-03-01) -
Anti-Müllerian hormone and risk of ovarian cancer in nine cohorts
за авторством: Jung, S, та інші
Опубліковано: (2017) -
Anti-Mullerian hormone and endometrial cancer: a multi-cohort study
за авторством: Fortner, RT, та інші
Опубліковано: (2017) -
Temporal reproducibility of IgG and IgM autoantibodies in serum from healthy women
за авторством: T. V. Clendenen, та інші
Опубліковано: (2022-04-01) -
Genetic Polymorphisms in Vitamin D Metabolism and Signaling Genes and Risk of Breast Cancer: A Nested Case-Control Study.
за авторством: Tess V Clendenen, та інші
Опубліковано: (2015-01-01)